Jean-Luc Bélingard

Jean-Luc Bélingard, born in 1948, is a French business executive, chairman and CEO of bioMérieux from 2011 to December 2017.

Biography
Jean-Luc Bélingard is a graduate of HEC Paris and holds an MBA from Cornell University.

He had a career in the pharmaceutical industry, notably at Merck & Co. and Hoffmann-La Roche where he was a member of the group's executive committee and general manager of Roche Diagnostic. From 2002 to 2010, he served as chairman and CEO of the Ipsen group, a French pharmaceutical group present in several therapeutic areas including oncology, neurology and endocrinology.

As of January 1, 2011, he joined BioMérieux as chairman and CEO. Alexandre Mérieux succeeded him in December 2017.

He is also a director of Celera Genomics and Laboratory Corporation of America.